Plain-English translation of NCT06104007 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Coronary Artery Disease research guide →This trial is testing a medical device called Genoss® DCB — a special balloon catheter coated with a medication called paclitaxel — to help treat a condition where a stent placed in your coronary artery becomes blocked again over time. The balloon is designed with vitamin E and other special coatings to reduce the risk of the blockage returning. The study will follow 1,000 patients to see how well and safely this treatment works over the long term.
After a stent is placed in a coronary artery, sometimes the artery can become blocked again, a problem called in-stent restenosis. This medication-coated balloon offers a new way to treat this blockage without needing another stent, and the study aims to confirm it works safely and effectively in a large group of patients.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will receive the Genoss® DCB treatment as part of a heart procedure to open your blocked stent. After the procedure, you will be asked to return for follow-up visits and monitoring to help doctors track how well the treatment is working and whether any side effects occur. The study involves tracking your heart health over time through clinic visits and medical assessments.
AI-generated summary from trial data · Jun 20, 2026 · Not medical advice
South Korea
Sponsor
Seoul National University Hospital
Enrollment target
~1,000 participants
Started
August 2023
Primary completion
June 2028
Age range
19 Years and older
Last updated on clinicaltrials.gov in October 2023.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Bon-Kwon Koo, MD, PhD
Seoul National University Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.